Reyvow
NDC 0002-4491, lasmiditan, tablet, from Eli Lilly and Company.
- Product NDC
- 0002-4491
- Status
- Listed
- Labeler
- Eli Lilly and Company
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA211280
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/0002-4491 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LASMIDITAN100 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0002-4491-08 | 00002449108 | 2 BLISTER PACK in 1 CARTON (0002-4491-08) / 4 TABLET in 1 BLISTER PACK |
| 0002-4491-62 | 00002449162 | 1 BLISTER PACK in 1 CARTON (0002-4491-62) / 2 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/aea3358c-ff41-4490-9e6d-c7bf7b3de13fNADAC price for package 00002449108
GET /v1/drugs/nadac/00002449108
Use it
Look up 0002-4491 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0002-4491 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0002-4491. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.